Johan R. Lillehaug

Molecular Biology Consortium — United States

Medicine · Health Sciences

37h-index5.3kcitations138works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Peptidase Inhibition and Analysis(23), Cancer-related Molecular Pathways(22), Ubiquitin and proteasome pathways(22), DNA Repair Mechanisms(9), Epigenetics and DNA Methylation(9)

Publications137 total

Data from Gene Expression Profiling–Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome
2023Open Access
Supplementary Data from Gene Expression Profiling–Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome
2023Open Access
Supplementary Data from Gene Expression Profiling–Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome
2023Open Access
Data from Gene Expression Profiling–Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome
2023Open Access
SIX3 and SIX6 interact with GEMININ via C-terminal regions
Biochemistry and Biophysics Reports·2019· 2 citedOpen Access
Two tales of Annexin A2 knock-down: One of compensatory effects by antisense RNA and another of a highly active hairpin ribozyme
Biochemical Pharmacology·2019· 7 citedOpen Access
CorA Is a Copper Repressible Surface-Associated Copper(I)-Binding Protein Produced in Methylomicrobium album BG8
PLoS ONE·2014· 24 citedOpen Access
CXXC5 (Retinoid-Inducible Nuclear Factor, RINF) is a Potential Therapeutic Target in High-Risk Human Acute Myeloid Leukemia
Oncotarget·2013· 22 citedOpen Access
Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma
Clinical & Experimental Metastasis·2013· 20 citedOpen Access
Abstract 3139: Identification and functional studies of p53 mutants detected in breast cancers after chemotherapy treatment.
Cancer Research·2013
Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin
Biochimica et Biophysica Acta (BBA) - General Subjects·2012· 10 cited
The Methylococcus capsulatus (Bath) Secreted Protein, MopE*, Binds Both Reduced and Oxidized Copper
PLoS ONE·2012· 23 citedOpen Access
Human Protein N-terminal Acetyltransferase hNaa50p (hNAT5/hSAN) Follows Ordered Sequential Catalytic Mechanism
Journal of Biological Chemistry·2012· 25 citedOpen Access
Using VAAST and massively parallel sequencing to characterize a novel disorder caused by protein N-terminal acetyltransferase deficiency
2012
The role of ROS in the etiology of cancer and in ageing
2012
Receptor for Activated Protein C Kinase 1 (RACK1) Is Overexpressed in Papillary Thyroid Carcinoma
Thyroid·2011· 17 cited
Massively parallel sequencing identifies a previously unrecognized X-linked disorder resulting in lethality in male infants owing to amino-terminal acetyltransferase deficiency
Genome biology·2011Open Access
Massively parallel sequencing identifies a previously unrecognized X-linked disorder resulting in lethality in male infants owing to amino-terminal acetyltransferase deficiency
Genome biology·2011· 8 citedOpen Access
The Human N-Alpha-Acetyltransferase 40 (hNaa40p/hNatD) Is Conserved from Yeast and N-Terminally Acetylates Histones H2A and H4
PLoS ONE·2011· 125 citedOpen Access
Using VAAST to Identify an X-linked Disorder Resulting in Lethality in Male Infants Due to N-Terminal Acetyltransferase Deficiency
The American Journal of Human Genetics·2011· 12 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Jan Erik Varhaug(20), Thomas Arnesen(17), Per Eystein Lønning(9), Rune Evjenth(7), Stian Knappskog(6), Darina Gromyko(6), Øystein Fluge(6), Harald B. Jensen(5), Odd André Karlsen(5), Lars A. Akslen(4), Vidar Staalesen(4), Petra Van Damme(3), Kris Gevaert(3), Øivind Larsen(3), Jürgen Geisler(3), Laila J. Reigstad(3), Dave Anderson(3), Kjell Kleppe(3), Kristian K. Starheim(3), Anita Ryningen(3)